Preparation of CRP . CRP was purified from ascites or pleural fluids by affinity chromatography based on the calcium-dependent binding of CRP to CPS (18) . The procedure for this purification will be published in detail .'
Preparation ofCRP-DefccientAcute Phase Serum . Acute phase serum (CRP >-100 Wg/ml) which showed maximum reactivity with poly-L-lysine (PLL) and protamine was centrifuged (10,000 g) for 20 min at 4°C, and the lipids were removed. The serum was applied to a CPS-Biogel column' (BioRad Laboratories, Richmond, Calif.) equilibrated with veronal-buffered saline with optimum divalent cations (VBS++) and NaN3 (0 .002 M) at 4°C. The serum eluate was monitored by A2aoom and hemolytic C activity, and was frozen immediately and maintained at -70°C until use.
Assay for Hemolytic C and C-Component Activities . The effect of polycations on the hemolytic C activity of normal and acute phase sera was determined by incubation of serum (0 .1 ml), buffer (0 .35 ml 2/3 GVB"), and polycation (0 .05 ml) for 60 min at 30°C (17) . When CRP was added, the total vol remained 0.5 ml, and the polycation was added last. When agents such as phosphorylcholine, tetra-L-lysine (TLL), or Polybrene were assayed from their ability to inhibit polycation-CRPinduced consumption of C, varying doses of these substances were prereacted with CRP for 30 min at 37°C in a total vol of 0.2 ml ; additional buffer, serum, and reactive polycation (e .g ., PLL) or CPS were added in that order to bring the final reaction vol to 0.5 ml, and the mixture was preincubated for 60 min at 30°C . Residual hemolytic C and C1, C4, and C2 component activities were determined as previously described (26, 27, 31) . Assays for residual hemolytic C3, C5, and C6 activities were performed in tubes according to the methods described by Lachmann et al . (29) . C7 was measured by hemolytic radial diffusion also as described by Lachmann et al . (29) . C8 and C9 hemolytic activities were assayed according to Vroon et al . (32) .
Results
Effect of PLL Polymers on Hemolytic C Activity in Acute Phase Serum . Polymers of L-lysine were found to initiate C consumption selectively in acute phase serum. The reactivity varied markedly according to polymer size. Polymers of 2,000, 4,000, and 8,000 daltons showed maximum reactivity, inducing 40-100% C consumption at concentrations (5-10 Ag/ml preincubation mixture) 10-fold lower than those (50-100 kkg/ml) showing anticomplementary activity in normal serum ( Fig. 1 and Table 1 ) . Polymers of 1,700, 11,000, and 23,000 daltons showed moderate (15-30%) C-consuming activity, while L-lysine, lysyl-L-lysine, TLL, and the largest PLL polymers tested (70,000, 178,000, and 400,000 daltons, respectively) . had no (<15%) significant C-consuming activity selectively in acute phase serum.
All the polymers larger than the tetramer, independent of the degree of polymerization, were anticomplementary at concentrations >50 ,u,g/ml in both normal and acute phase sera. This nonselective anticomplementary effect, which occurred at concentrations 10-to 20-fold higher than those inducing C consumption selectively in acute phase sera, may be analogous to the nonspecific "fixation" of C by PLL in the sera of normal and immunized rabbits reported by Arnon et al. (33) , and probably involves direct interaction with certain C components.
Identification of PLL-Induced C Consumption in Acute Phase Serum as a CRP-Mediated Reaction . The consumption of C in acute phase serum initiated by PLL, like protamine-initiated C consumption, was found to be mediated via CRP . Absorption of CRP from acute phase serum (250 hg CRP/ml) by passage through the CPS-Biogel column resulted in loss of ability of PLL (4,000 daltons) ' Osmand to induce C consumption, and the addition of purified CRP (250 /.g/ml) completely restored this activity ( Fig. 2 A) ; PLL also resulted in C depletion in normal human serum to which purified ascites CRP had been added (Fig. 2 B) . In these normal human serum-CRP reaction systems, the amount of PLL optimal for peak CRP-mediated C consumption (2.5 pg/ml) consistently was less than that required for maximal activity in both acute phase and absorbedreconstituted acute phase sera (5 .0-10 .0 /Ag/ml) . The optimal polycation concentration appeared to be a function ofboth the individual CRP preparation and the serum in which the activity was assayed. The higher polycation concentration required for optimal activity in acute phase serum may reflect the presence of polyanionic substances known to be elevated during the acute phase. The relationship between polymer size and C-consuming activity observed in acute phase serum also could be identified in normal human serum to which CRP was added. Finally, phosphorylcholine inhibited PLL-initiated consumption of C ( Effect of representative polymers of L-lysine (PLL) on C activity of normal (<3 Wg CRP/ml) and acute phase (75 gg CRP/ml) sera . Residual C activity was measured after 60 min preincubation at 30°C . With small amounts of PLL (<50,ug/ml ; optimal, 10 wg/ml), C consumption was seen selectively in acute phase sera, and only with polymers of optimal (1,700-23,000 daltons) size . Polymers ?1,700 daltons were anti-C in amounts >50 Wg/ml. Reactivity of Synthetic and Natural Polycations in CRP-Containing Serum Systems* * 0.1 ml serum, 0.35 ml buffer (2/3 GVB++), and 0.05 ml polycation were preincubated for 60 min at 37°C, and assayed for residual total hemolytic C activity ; +++ represents 60-100%; ++, 30-60%; +, 15-30% ; and -, 0-15% complement consumption .
was inhibited by glycerophosphory1choline and acetylcholine with descreasing efficiency . C Component Depletion Profile during CRP-PLL Interactions . PLL (2,000 or 4,000 daltons) added to normal human serum-CRP mixtures induced efficient depletion of hemolytic C1, C4, and C2 and substantial (50-80%) depletion of C3 and C5 (Fig . 4) . C6 activity showed minimal depletion and levels of C7, C8, and C9 were unaffected . Similar depletion profiles were found upon interaction of protamine with CRP. PLL and CRP alone each consumed C4 at the concentrations used, which were 10-to 20-fold lower than the amounts inducing depletion of total C activity . Higher concentrations of PLL resulted in C1-consuming activity in absence of depletion of C4 . The basis of the anti-C4 activity of CRP was not clear ; it was dose dependent, occurred also in serum preheated to 56°C for 30 min to inactivate C1, and was not inhibited by phosphorylcholine .
Effect of Other Synthetic Polycations on C Consumption in CRP-Containing Sera . Synthetic polycations in addition to PLL were tested for C consumption in both acute phase serum and normal serum to which CRP had been added. Low mol wt polymers of L-arginine (17,000 and 15,000-50,000 daltons) showed intermediate (25%) C consumption which was optimal at 5-10 Ag/ml (Table I) , an activity equivalent to L-lysine polymers of that size range. A higher mol wt polymer Of L-arginine (65,000 daltons), like PLL polymers in this size range, showed no C-consuming activity (Table I) . Polymers (5,000-20,000 and 165,000 daltons) of L-ornithine, which differs from L-lysine by a single methylene group, and Polybrene (5,000-10,000 daltons), a synthetic polymer of hexadimethrine bromide, did not consume C in the presence of CRP (Table I) .
Effects of Naturally Occurring Polycations on C Consumption in CRP-Containing Serum. Several naturally occurring polycations, including histones, C consumption by PLL (4,000 daltons) in the presence and absence of CRP (250 hg/ml) . (A) Effect of PLL in acute phase serum, acute phase serum absorbed with CPS by affinity chromatography, and absorbed acute phase serum to which purified CRP had been added; (B) PLL-initiated C consumption in normal human serum in the presence and absence of CRP (250 hg/ml) . C consumption was seen only in the presence of CAP in both normal and acute phase sera . MBP, and leukocyte cationic proteins, were tested for their ability to consume C in the presence of CRP (Table I and Fig . 5 ). The histones showed marked (>80%) C-consuming activity when CRP was present, but none in its absence; the concentration of the lysine-rich histone required for 50% consumption was 10-fold lower than that of the arginine-rich histone (50 as compared to 500 wg/ml) . MBP derived from the cow, monkey, rabbit, and guinea pig likewise had pronounced C-consuming activity in the presence of CRP but none in its absence ; 50% C consumption was observed with approximately 100 gg bovine MBP/ml, and maximum reactivity of 80% or greater C consumption was observed with concentrations of 500 wg/ml or more. LCP showed dose-dependent C- Comparison of the inhibition of CPS-CRP-and PLL-CRP-induced C consumption by TLL, phosphorylcholine, and Polybrene . The relative inhibitory activity of these agents (Polybrene > phosphorylcholine > TLL) was identical in both systems ; larger amounts were required to inhibit C consumption initiated by CPS .
FIG . 4 .
Effect of PLL (2,000 daltons ; 2 .5 Wg/ml) and CRP (250 pg/ml serum) on C component hemolytic activities in normal human serum . The interaction of PLL and CRP induced marked depletion of C1-C5, but had little or no effect on C6-C9 .
consuming activity which was markedly potentiated in the presence of CRP; maximum C-consuming activity (>90%) in the presence of CRP was observed with approximately 300 Ag/ml LCP, while only 38% C consumption was observed in its absence. By contrast, lysozymes of both human and egg white origin showed no C-consuming activity . The C-depletion profiles resulting from the interaction of lysine-rich histones and MBP with CRP in normal human serum were essentially identical to that induced by PLL. The C consumption induced by lysine-rich histones and MBP was inhibited by phosphorylcholine; less phosphorylcholine was required for 50% inhibition of C consumption by the lysine-rich histones (7.8 x 10-s M) and MBP (3 x 10' M) than by PLL (2.4 x 10-5 M) or protamine (1 .8 x 10-5 M), indicating that CRP has a lower affinity for the lysine-rich histones and for MBP than it has for PLL or protamine.
Effect of Inactive Polycations on CRP-Mediated Consumption of C. TLL in amounts which had no effect on C consumption by immune complexes or zymosan inhibited CRP-polycation-mediated C consumption. Concentrations of 2.3 x 10-3 and 1.9 x 10-3 M resulted in 50% inhibition of PLL- (Fig. 3) and protamine-initiated C consumption, respectively ; consumption by histones and MBP was inhibited at concentrations approximately 2-to 4-fold lower. These results are consistent with the relative affinities of CRP for the polycations cited above. The affinity of CRP for TLL was found to be much lower than its affinity for phosphorylcholine, as evidenced by the 100-fold greater relative molar concentration of TLL required for inhibition of C activation . TLL also inhibited C depletion initiated by CPS (Fig . 3) ; the concentration (4 x 10-3 M) required was approximately twice that required for inhibition of C consumption by PLL. Twice as much phosphorylcholine also was required to inhibit C consumption induced by CPS (4.9 x 10-5 M) than that induced by PLL (2 .4 x 10-5 M), indicating that CRP has a greater affinity for CPS than for PLL. The other polycations which did not induce C consumption in the presence of CRP, including the higher molecular weight PLL (e.g., 400,000 daltons), Polybrene, poly-L-ornithine (5,000-20,000 daltons), and egg white lysozyme also inhibited C consumption by active polycations and CPS ; Polybrene was approximately 100-fold more effective than phosphorylcholine in this respect (Fig . 3) . Discussion CRP recently was found to be a potent activator ofthe C system when reacting with CPS and choline phosphatides (16) . While investigating polyanion-polycation-induced activation of C, we found that protamine also induced activation of the primary C pathway by interaction with CRP (17) . We therefore wondered whether polycations generally and certain naturally occurring cationic proteins specifically could represent significant reactivities for CRP, and in this way lead to initiation or modulation of the inflammatory response .
In the present investigation synthetic and naturally occurring polycations, including homopolymers of L-lysine (1,700-23,000 daltons) and arginine (15,000-50,000 daltons), histones, MBP, and LCP, were found to activate C via CRP. Smaller or larger polymers of L-lysine were inactive, suggesting an optimal size range consistent with the known molecular weights of the histones (34), MBP (35) , and LCP (22) . The active naturally occurring polycations are rich in lysine and arginine (17-25%) with varying ratios and distributions of these residues ; MBP, which has a random distribution of basic residues, showed the weakest reactivity with CRP. Other polycations of similar mol wt, including poly-Lornithine (5,000-20,000 daltons), Polybrene (5,000-10,000 daltons), and hen egg (14,000 daltons containing 13% lysine and arginine) (36) and human lysozymes were without activity . Thus, while the structural characteristics required for polycations to initiate CRP-mediated C activation are not yet clear, they would seem to include specific basic groups, polycation molecular size, basic residue distribution, tertiary structure, and/or critical intermolecular configuration.
Each of the polycations tested which failed to activate C in the presence of CRP was able to inhibit C activation by the active polycations as well as by CPS. It would seem that reactivity with CRP is a property of polycations generally, and additional alteration or aggregation of CRP is required for initiation of C consumption. Since phosphorylcholine also inhibited C consumption by both polycations and CPS, it appears that these react at an identical or overlapping combining site or sites on CRP . However, it should be noted that to date binding of polycations to CRP has been inferred only from these indirect studies involving C interactions.
CRP seems to have a lower affinity for polycations than for CPS since higher molar concentrations ofboth phosphorylcholine and polycation were required to inhibit C consumption by CPS than by the active polycations . Nonetheless, Polybrene was more effective than phosphorylcholine in inhibiting the C-consuming reactions of CRP . Polybrene, a heparin inhibitor, is a synthetic, linear polymeric, quaternary polyamine ; its increased capacity for inhibition may be a reflection of its polymeric nature rather than the activity of its monomeric unit, which was calculated to be less than that of phosphorylcholine . This interpretation is supported by the similar efficiency of inhibition of C consumption observed with the inactive 400,000 dalton polymer of L-lysine . Whatever the basis, such polycations may serve a physiological or pharmacological role as a consequence of an ability to modulate reactions of CRP .
Protamine-CRP-mediated C consumption had been reported to involve nonimmune activation of the primary C pathway characterized by marked depletion of C1, C4, and C2, with minimal effect on C3-9 (17) . However, in the present studies the interactions of CRP with PLL and other active polycations including protamine were shown also to deplete hemolytic C3 and C5. Selective depletion of Cl-C5 was seen also during CPS-CRP interactions,3 supporting earlier observations of significant C1, C4, and C2 depletion, electrophoretic conversion of C3, and distinct but lesser consumption of C3-9 by complexes of CRP and CPS (16) . Since recently CRP was found to initiate C-dependent lysis of erythrocytes passively coated with CPS (37), it seems to be a potent activator ofthe primary C pathway which under suitable conditions can initiate expression of the full biologic potential of the C system . Whether the interaction of CRP with active polycations results in C activation at the level of Clq as it does in CRP-CPS interactions (38) , and whether other serum factors are required, is not yet clear .
The naturally occurring polycations with capacity to react with CRP are of interest since these include leukocyte cationic proteins and histones, which are available and may accumulate at sites of injury and tissue destruction . Perhaps reactivity with CRP results in activation of C at inflammatory sites, in modulation of the ability of polycations to initiate mast cell (39) and platelet (40) activation, or in favoring of CRP binding at anionic cell surface sites. The reactivity of CRP with the MBP raises the question of CRP involvement in the pathogenesis of allergic encephalomyelitis, in which MBP has been implicated (41) . Further, since the structure of MBP has been extensively defined (35) , this protein and its fragments should facilitate definition ofthe combining site(s) of CRP ; such investigations have been initiated with Dr. Marian Kies of the National Institutes of Health, Bethesda, Md.
CRP thus provides an additional route to activation of C-dependent host reactions, supporting the concept that it is a modulator of the inflammatory process These considerations would seem to expand the potential role of CRP in the initiation and modulation of the inflammatory response .
